Topic List : Cancer
Stanford Medicine magazine: Cracking cancer’s code
A special report on cancer in Stanford Medicine magazine looks at innovations in cancer treatment, research and education.
Young adults don’t know what’s in vape products
Nicotine pods used for vaping need clearer labels to help young people understand what they are inhaling, a Stanford study concludes.
Cancer-associated mutations relatively common
Postmenopausal women with breast cancer are as likely as Ashkenazi Jewish women to carry inherited breast-cancer mutations that can inform treatment, a Stanford study found.
Industry-linked studies favorable to indoor tanning
Indoor-tanning studies with financial ties to the industry are likely to downplay risks and discuss the potential benefits of tanning, researchers have found.
Single number IDs deadly cancer cells
Stanford data scientists have shown that figuring out a single number can help them find the most dangerous cancer cells.
From antiviral to possible cancer drug
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice.
NCI director says cancer research booming
In a speech at Stanford, National Cancer Institute Director Norman Sharpless reported promising cancer mortality trends and described an encouraging landscape for research funding and drug approval.
Next generation of CAR-T cells possible
CAR-T cells are remarkably effective against blood cancers, but their effect can be transient as the cells become exhausted. Stanford researchers found a way to keep the cells effective in mice with human tumors.
Protein decoy stymies lung cancer in mice
Researchers at Stanford and UCSF slowed the spread of a type of nonsmall cell lung cancer in mice by neutralizing a single protein that would otherwise set off a chain reaction, causing runaway tumor growth.
Identifying who benefits from chemo drug
Anthracyclines can be effective against breast cancer but often have toxic side effects. Stanford researchers used gene expression levels to identify women most likely to benefit from the drugs, regardless of breast cancer type or stage.